Emergent BioSolutions Inc
NYSE:EBS

Watchlist Manager
Emergent BioSolutions Inc Logo
Emergent BioSolutions Inc
NYSE:EBS
Watchlist
Price: 12.22 USD -1.69% Market Closed
Market Cap: 641.8m USD

Wall Street
Price Targets

EBS Price Targets Summary
Emergent BioSolutions Inc

Wall Street analysts forecast EBS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EBS is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

Lowest
Price Target
12.12 USD
1% Downside
Average
Price Target
13.77 USD
13% Upside
Highest
Price Target
15.75 USD
29% Upside
Emergent BioSolutions Inc Competitors:
Price Targets
URGN
Urogen Pharma Ltd
54% Upside
KURN
Kuros Biosciences AG
27% Upside
BIOCON
Biocon Ltd
13% Upside
SVRA
Savara Inc
66% Upside
VNDA
Vanda Pharmaceuticals Inc
66% Upside
XFOR
X4 Pharmaceuticals Inc
90% Upside
FOLD
Amicus Therapeutics Inc
14% Upside
688235
Beigene Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Emergent BioSolutions Inc

For the last 13 years the compound annual growth rate for Emergent BioSolutions Inc's revenue is 11%. The projected CAGR for the next 3 years is -13%.

11%
Past Growth
-13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Emergent BioSolutions Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Emergent BioSolutions Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EBS's stock price target?
Price Target
13.77 USD

According to Wall Street analysts, the average 1-year price target for EBS is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

What is Emergent BioSolutions Inc's Revenue forecast?
Projected CAGR
-13%

For the last 13 years the compound annual growth rate for Emergent BioSolutions Inc's revenue is 11%. The projected CAGR for the next 3 years is -13%.

Back to Top